Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
- PMID: 33675692
- PMCID: PMC9191863
- DOI: 10.1016/j.cell.2021.02.012
Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care
Abstract
The prevalence of type 2 diabetes and obesity has risen dramatically for decades and is expected to rise further, secondary to the growing aging, sedentary population. The strain on global health care is projected to be colossal. This review explores the latest work and emerging ideas related to genetic and environmental factors influencing metabolism. Translational research and clinical applications, including the impact of the COVID-19 pandemic, are highlighted. Looking forward, strategies to personalize all aspects of prevention, management and care are necessary to improve health outcomes and reduce the impact of these metabolic diseases.
Keywords: circadian clock; diet; environment; exercise; genetics; inflammation; metabolism; personalized medicine; thermal regulation; treatment.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests. J.R.Z. is member of Cell Advisory Board.
Figures





Similar articles
-
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.Nat Rev Endocrinol. 2021 Mar;17(3):135-149. doi: 10.1038/s41574-020-00462-1. Epub 2021 Jan 21. Nat Rev Endocrinol. 2021. PMID: 33479538 Review.
-
Furthering Precision Medicine Genomics With Healthy Living Medicine.Prog Cardiovasc Dis. 2019 Jan-Feb;62(1):60-67. doi: 10.1016/j.pcad.2018.12.009. Epub 2019 Jan 2. Prog Cardiovasc Dis. 2019. PMID: 30610883 Review.
-
A rational approach to COVID-19.Hum Genomics. 2020 Dec 22;14(1):47. doi: 10.1186/s40246-020-00300-5. Hum Genomics. 2020. PMID: 33353565 Free PMC article.
-
Epigenetic processing in cardiometabolic disease.Atherosclerosis. 2019 Feb;281:150-158. doi: 10.1016/j.atherosclerosis.2018.09.029. Epub 2018 Sep 26. Atherosclerosis. 2019. PMID: 30290963 Review.
-
Precision Medicine in Obesity and Type 2 Diabetes: The Relevance of Early-Life Exposures.Clin Chem. 2018 Jan;64(1):130-141. doi: 10.1373/clinchem.2017.273540. Epub 2017 Nov 2. Clin Chem. 2018. PMID: 29097511 Review.
Cited by
-
The Role of AMPK Signaling in Brown Adipose Tissue Activation.Cells. 2021 May 6;10(5):1122. doi: 10.3390/cells10051122. Cells. 2021. PMID: 34066631 Free PMC article. Review.
-
Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.Cancers (Basel). 2022 Mar 25;14(7):1679. doi: 10.3390/cancers14071679. Cancers (Basel). 2022. PMID: 35406450 Free PMC article. Review.
-
FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity.bioRxiv [Preprint]. 2023 Feb 20:2023.02.19.529127. doi: 10.1101/2023.02.19.529127. bioRxiv. 2023. Update in: Cell Metab. 2023 May 2;35(5):887-905.e11. doi: 10.1016/j.cmet.2023.03.018. PMID: 36865221 Free PMC article. Updated. Preprint.
-
Variations in Fibrinogen-like 1 (FGL1) Gene Locus as a Genetic Marker Related to Fat Deposition Based on Pig Model and Liver RNA-Seq Data.Genes (Basel). 2022 Aug 9;13(8):1419. doi: 10.3390/genes13081419. Genes (Basel). 2022. PMID: 36011329 Free PMC article.
-
Metabolic Pathways Involved in Formation of Spontaneous and Lipopolysaccharide-Induced Neutrophil Extracellular Traps (NETs) Differ in Obesity and Systemic Inflammation.Int J Mol Sci. 2021 Jul 19;22(14):7718. doi: 10.3390/ijms22147718. Int J Mol Sci. 2021. PMID: 34299338 Free PMC article.
References
-
- Achebak H., Devolder D., Ballester J. Trends in temperature-related age-specific and sex-specific mortality from cardiovascular diseases in Spain: a national time-series analysis. Lancet Planet. Health. 2019;3:e297–e306. - PubMed
-
- Ahlqvist E., Storm P., Käräjämäki A., Martinell M., Dorkhan M., Carlsson A., Vikman P., Prasad R.B., Aly D.M., Almgren P., et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–369. - PubMed
-
- Al-Mrabeh A., Zhyzhneuskaya S.V., Peters C., Barnes A.C., Melhem S., Jesuthasan A., Aribisala B., Hollingsworth K.G., Lietz G., Mathers J.C., et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metab. 2020;31:233–249 e234. - PubMed
-
- Ameln H., Gustafsson T., Sundberg C.J., Okamoto K., Jansson E., Poellinger L., Makino Y. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005;19:1009–1011. - PubMed
-
- American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical